Search

Your search keyword '"Westwood, JA"' showing total 85 results

Search Constraints

Start Over You searched for: Author "Westwood, JA" Remove constraint Author: "Westwood, JA"
85 results on '"Westwood, JA"'

Search Results

1. Generating CAR T cells from tumor-infiltrating lymphocytes.

2. Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma

3. An ultrastructural investigation of tumors undergoing regression mediated by immunotherapy

4. Cross-talk between tumors can affect responses to therapy

5. Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice

7. Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy

8. Routes of Delivery for CpG and Anti-CD137 for the Treatment of Orthotopic Kidney Tumors in Mice

9. Foxp3 Expression in Macrophages Associated with RENCA Tumors in Mice

10. Clinical application of genetically modified T cells in cancer therapy

14. Environmental enrichment does not impact on tumor growth in mice.

15. Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library Approach

17. Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice

19. Strategic antisubmarine warfare

20. New Soviet military doctrine

21. Soviet reaction to the U.S. Maritime Strategy

22. Developments in Soviet air defence

29. Generating CAR T cells from tumor-infiltrating lymphocytes.

30. Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma.

31. An ultrastructural investigation of tumors undergoing regression mediated by immunotherapy.

32. Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment.

33. Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.

34. Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice.

36. Psychological distress, quality of life, symptoms and unmet needs of colorectal cancer survivors near the end of treatment.

37. Cross-talk between tumors can affect responses to therapy.

38. Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors.

39. Foxp3 expression in macrophages associated with RENCA tumors in mice.

40. Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancers.

41. The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy.

42. Clinical application of genetically modified T cells in cancer therapy.

43. Routes of delivery for CpG and anti-CD137 for the treatment of orthotopic kidney tumors in mice.

44. Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.

45. Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia.

46. Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment.

47. Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy.

48. Gene-engineered T cells for cancer therapy.

49. Environmental enrichment does not impact on tumor growth in mice.

50. Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor.

Catalog

Books, media, physical & digital resources